DS
Dasapaiyya Srikanth Rao
About Dasapaiyya Srikanth Rao
Data last updated:
Dasapaiyya Srikanth Rao has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Mangalore Institute Of Oncology Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Mangalore Institute Of Oncology Private Limited at ₹56.81 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Mar 2024 | 2006 | ₹56.81 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dasapaiyya Srikanth Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dasapaiyya Srikanth Rao
Dasapaiyya Srikanth Rao has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Mangalore Institute Of Oncology Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Mangalore Institute Of Oncology Private Limited at ₹56.81 Cr (FY 2025).
Dasapaiyya Srikanth Rao is associated with 1 company as Director, including Mangalore Institute Of Oncology Private Limited (₹56.81 Cr).
Dasapaiyya Srikanth Rao has expertise in General Business.
Dasapaiyya Srikanth Rao has 2 years in corporate governance.
By reported revenue, the largest current company of Dasapaiyya Srikanth Rao is Mangalore Institute Of Oncology Private Limited, with revenue of ₹56.81 Cr (FY 2025).
Dasapaiyya Srikanth Rao currently holds positions at 1 company: Mangalore Institute Of Oncology Private Limited (₹56.81 Cr).